Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction

被引:14
作者
Jose, P [1 ]
Tomson, C [1 ]
Skali, H [1 ]
Rouleau, J [1 ]
Braunwald, E [1 ]
Arnold, JM [1 ]
Cuddy, T [1 ]
Sussex, B [1 ]
Bernstein, V [1 ]
Pfeffer, M [1 ]
Solomon, S [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
10.1016/j.jacc.2006.01.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1725 / 1727
页数:3
相关论文
共 10 条
[1]   The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The cardiovascular health study [J].
Barzilay, JI ;
Peterson, D ;
Cushman, M ;
Heckbert, SR ;
Cao, JJ ;
Blaum, C ;
Tracy, RP ;
Klein, R ;
Herrington, DM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (01) :25-34
[2]   Prognostic significance of hypertension and albuminuria for early mortality after acute myocardial infarction [J].
Berton, G ;
Cordiano, R ;
Mbaso, S ;
De Toni, R ;
Mormino, P ;
Palatini, P .
JOURNAL OF HYPERTENSION, 1998, 16 (04) :525-530
[3]   Microalbuminuria during acute myocardial infarction - A strong predictor for 1-year mortality [J].
Berton, G ;
Cordiano, R ;
Palmieri, R ;
Cucchini, F ;
De Toni, R ;
Palatini, P .
EUROPEAN HEART JOURNAL, 2001, 22 (16) :1466-1475
[4]   Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study [J].
Culleton, BF ;
Larson, MG ;
Parfrey, PS ;
Kannel, WB ;
Levy, D .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (01) :1-8
[5]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[6]   Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[7]  
LAFFEYETTE RA, 1996, DIS KIDNEY, P339
[8]   EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL [J].
PFEFFER, MA ;
BRAUNWALD, E ;
MOYE, LA ;
BASTA, L ;
BROWN, EJ ;
CUDDY, TE ;
DAVIS, BR ;
GELTMAN, EM ;
GOLDMAN, S ;
FLAKER, GC ;
KLEIN, M ;
LAMAS, GA ;
PACKER, M ;
ROULEAU, J ;
ROULEAU, JL ;
RUTHERFORD, J ;
WERTHEIMER, JH ;
HAWKINS, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) :669-677
[9]   Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction -: The Survival and Ventricular Enlargement (SAVE) study [J].
Tokmakova, MP ;
Skali, H ;
Kenchaiah, S ;
Braunwald, E ;
Rouleau, JL ;
Packer, M ;
Chertow, GM ;
Moyé, LA ;
Pfeffer, MA ;
Solomon, SD .
CIRCULATION, 2004, 110 (24) :3667-3673
[10]   White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes [J].
Tong, PC ;
Lee, KF ;
So, WY ;
Ng, MH ;
Chan, WB ;
Lo, MK ;
Chan, NN ;
Chan, JC .
DIABETES CARE, 2004, 27 (01) :216-222